Front Desk: 469-391-0070
Levodopa for Parkinson’s Disease: Dosage, Side Effects & Uses
Summary of Key Points
Levodopa is a commonly prescribed medication for managing Parkinson’s disease and other movement disorders. It works by replenishing dopamine levels in the brain, which helps improve motor function. Levodopa is often used in combination with other medications to enhance its effectiveness. Always consult your healthcare provider before starting or adjusting your dosage. Our telemedicine providers are available to assist you in managing your treatment plan.
Names of Medication
US Brand Name: Sinemet (Levodopa/Carbidopa)
US Brand Name: Rytary (Levodopa/Carbidopa extended-release)
US Brand Name: Parcopa (Levodopa/Carbidopa orally disintegrating tablets)
The generic name refers to the active ingredient, while the brand name is the marketed version. The generic name is listed in parentheses.
Pharmacologic Category
Dopamine Precursor
Antiparkinson Agent
Levodopa Dosing for Parkinson’s Disease and Other Conditions
Levodopa is prescribed for Parkinson’s disease, restless legs syndrome, and other movement disorders. The dosage varies depending on the condition being treated. Always consult your doctor before making any changes to your dose. You can also schedule a telemedicine appointment with one of our providers to discuss your treatment plan.
Parkinson’s Disease Treatment
Initial Dose: 300 mg to 400 mg per day, divided into 3 to 4 doses.
Maintenance Dose: 400 mg to 800 mg per day, divided into 3 to 4 doses.
Doses are adjusted based on individual response and tolerance. Treatment is typically long-term.
Restless Legs Syndrome
Initial Dose: 100 mg to 200 mg at bedtime.
Maintenance Dose: 200 mg to 400 mg at bedtime.
The duration of treatment depends on symptom relief and how well the medication is tolerated.
Parkinsonism
Initial Dose: 300 mg to 600 mg per day, divided into 3 to 4 doses.
Maintenance Dose: 600 mg to 1,000 mg per day, divided into 3 to 4 doses.
Treatment is usually long-term and adjusted as needed based on response.
Multiple System Atrophy
Initial Dose: 300 mg to 400 mg per day, divided into 3 to 4 doses.
Maintenance Dose: 400 mg to 800 mg per day, divided into 3 to 4 doses.
Long-term treatment is often required for this condition.
Progressive Supranuclear Palsy
Initial Dose: 300 mg to 400 mg per day, divided into 3 to 4 doses.
Maintenance Dose: 400 mg to 800 mg per day, divided into 3 to 4 doses.
The treatment plan is adjusted based on how well the patient responds and tolerates the medication.
Lewy Body Dementia
Initial Dose: 300 mg to 400 mg per day, divided into 3 to 4 doses.
Maintenance Dose: 400 mg to 800 mg per day, divided into 3 to 4 doses.
Long-term treatment is typically necessary for managing symptoms.
Drug-Induced Parkinsonism
Initial Dose: 300 mg to 400 mg per day, divided into 3 to 4 doses.
Maintenance Dose: 400 mg to 800 mg per day, divided into 3 to 4 doses.
The duration of treatment depends on the severity of symptoms and the patient’s response to the medication.
Corticobasal Degeneration
Initial Dose: 300 mg to 400 mg per day, divided into 3 to 4 doses.
Maintenance Dose: 400 mg to 800 mg per day, divided into 3 to 4 doses.
Long-term treatment is often necessary to manage this condition.
Essential Tremor
Initial Dose: 100 mg to 200 mg per day, divided into 2 to 3 doses.
Maintenance Dose: 200 mg to 400 mg per day, divided into 2 to 3 doses.
The duration of treatment depends on symptom control and how well the medication is tolerated.
Dystonia
Initial Dose: 300 mg to 400 mg per day, divided into 3 to 4 doses.
Maintenance Dose: 400 mg to 800 mg per day, divided into 3 to 4 doses.
Long-term treatment may be required to manage symptoms effectively.
Dosage Forms and Strengths of Levodopa
Immediate-release tablets: 100 mg, 250 mg
Extended-release tablets: 100 mg/25 mg, 200 mg/50 mg (Levodopa/Carbidopa)
Orally disintegrating tablets: 100 mg/25 mg, 200 mg/50 mg (Levodopa/Carbidopa)
Capsules (extended-release): 95 mg/23.75 mg, 145 mg/36.25 mg, 195 mg/48.75 mg, 245 mg/61.25 mg (Levodopa/Carbidopa)
Contraindications for Levodopa Use
A contraindication is a specific condition or situation where a medication should not be used because it may cause harm. If you have any of the following conditions, you should avoid taking Levodopa or discuss its use carefully with your healthcare provider before starting treatment.
Narrow-angle glaucoma: Levodopa can increase eye pressure, which may worsen this type of glaucoma.
Severe cardiovascular disease: Levodopa can affect blood pressure and heart rate, posing risks for individuals with heart conditions.
Severe liver or kidney disease: These organs are responsible for processing medications. If they are not functioning properly, Levodopa could accumulate in the body to unsafe levels.
History of melanoma or suspicious skin lesions: Levodopa has been associated with an increased risk of melanoma. If you have a history of melanoma or unusual skin lesions, this medication may not be suitable for you.
Use of non-selective monoamine oxidase inhibitors (MAOIs): Medications such as phenelzine (Nardil) or tranylcypromine (Parnate) can dangerously interact with Levodopa, potentially leading to a life-threatening increase in blood pressure.
Drug to Drug Interactions with Levodopa
Levodopa can interact with various medications, potentially altering its effectiveness or increasing the risk of side effects. It’s important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements. Some common medications that may interact with Levodopa include:
- Non-selective MAO inhibitors: Phenelzine (Nardil), Tranylcypromine (Parnate) – These can lead to dangerous increases in blood pressure when combined with Levodopa.
- Antipsychotics: Haloperidol (Haldol), Risperidone (Risperdal), Olanzapine (Zyprexa) – These medications can reduce the effectiveness of Levodopa.
- Antihypertensives: Methyldopa (Aldomet) – This combination may cause a significant drop in blood pressure, leading to dizziness or fainting.
- Iron supplements: Ferrous sulfate – Iron can interfere with Levodopa absorption, reducing its effectiveness.
- Metoclopramide: (Reglan) – This drug can block Levodopa’s action in the brain, diminishing its benefits.
Levodopa in Pregnancy: Is It Safe?
Levodopa is classified as a pregnancy category C drug by the FDA, meaning that while no well-controlled studies have been conducted in humans, animal studies suggest potential risks to the fetus. The decision to use Levodopa during pregnancy should be made after carefully weighing the benefits and risks with your healthcare provider. If you are pregnant or planning to become pregnant, it’s essential to consult your doctor to determine the most appropriate course of action. Our telemedicine providers are available to help you make an informed decision.
Levodopa While Breastfeeding: What You Need to Know
Levodopa is excreted in breast milk, and its effects on a breastfeeding infant are not fully understood. It is generally recommended to avoid breastfeeding while taking Levodopa, as it may affect milk production and could potentially harm the baby. Discuss the risks and benefits with your healthcare provider to determine the best approach for you and your child. If you have concerns, our telemedicine providers can offer guidance to help you make the best decision for your family.
Estimated Cost of Levodopa Medication
The cost of Levodopa can vary depending on the pharmacy and your location. With a GoodRx coupon, the estimated price for a 30-day supply of generic Levodopa without insurance ranges from $10 to $30. Brand-name versions, such as Sinemet, tend to be more expensive, with prices ranging from $150 to $300 for a 30-day supply. Be sure to check with your pharmacy for the most accurate pricing, and consider using a coupon to help reduce the cost.
Possible Alternatives to Levodopa for Parkinson’s Disease Treatment
While Levodopa is a common treatment for several neurological conditions, there are alternative treatments and lifestyle changes that may be considered. Always consult your healthcare provider before making any changes to your treatment plan. Our telemedicine providers can help you explore these options.
- Parkinson’s disease: Alternatives include dopamine agonists like pramipexole (Mirapex) or ropinirole (Requip), MAO-B inhibitors like selegiline (Eldepryl), and lifestyle changes such as regular exercise and physical therapy.
- Restless legs syndrome: Dopamine agonists like ropinirole (Requip) or gabapentin (Neurontin) may be used. Lifestyle modifications, such as improving sleep hygiene and reducing caffeine intake, can also be beneficial.
- Parkinsonism: Anticholinergic medications like benztropine (Cogentin) or amantadine (Symmetrel) may be considered as alternatives.
- Multiple system atrophy: Treatment may include medications to manage symptoms, such as fludrocortisone for low blood pressure, along with physical therapy to improve mobility.
- Progressive supranuclear palsy: While there is no cure, medications like amantadine (Symmetrel) and physical therapy can help manage symptoms.
- Lewy body dementia: Cholinesterase inhibitors like donepezil (Aricept) may be used to manage cognitive symptoms, along with lifestyle changes such as cognitive exercises.
- Drug-induced parkinsonism: Stopping the offending drug and switching to alternatives may help resolve symptoms.
- Corticobasal degeneration: Although there is no cure, physical therapy and medications like amantadine (Symmetrel) may help manage symptoms.
- Essential tremor: Beta-blockers like propranolol (Inderal) or anticonvulsants like primidone (Mysoline) are common alternatives. Lifestyle changes, such as reducing caffeine intake, may also help.
- Dystonia: Botulinum toxin injections (Botox) or anticholinergic medications like trihexyphenidyl (Artane) may be considered as alternatives.
Recent Updates on Levodopa Research
Recent research on Levodopa has focused on improving its effectiveness and minimizing side effects. One promising area is the development of extended-release formulations that provide more consistent symptom control throughout the day. Researchers are also exploring the use of Levodopa in combination with other medications to enhance its benefits and potentially slow the progression of Parkinson’s disease.
Another area of interest is Levodopa’s potential neuroprotective effects. While traditionally used to manage symptoms, some studies suggest that Levodopa may help slow the progression of neurodegenerative diseases. However, more research is needed to confirm these findings.
Ongoing clinical trials are investigating Levodopa’s use in conditions beyond Parkinson’s disease, such as restless legs syndrome and other movement disorders. If you are interested in participating in a clinical trial or learning more about the latest developments, our telemedicine providers can guide you through the available options.
